Will there be guidance for spirometry tests specific to the study and patient population?

Not for this study. Whereas in disease modification studies the primary endpoint (FVC) is derived from the spirometry and hence it is critical to standardise its assessment, in this study it is a routine safety assessment and so there is no need for specific measures around its collection.